FAP and neoplasm: Both tracers were subjected to a thorough preclinical evaluation including in vitro FAP binding assays, in vivo stability testing and, PET/CT imaging and ex vivo biodistribution studies using HEK293T:hFAP tumor xenograft mouse model.